MedInTech
Latest round
- Series B
Last raised
- May 2024
Total raised
- $21M
Investors
- 11
About MedInTech
D., MedInTech Inc. operates as a developer of a medical endoscope system that uses AI technology to diagnose diseases for healthcare institutions. In May 2024, MedInTech Inc. The company provides a wide range of medical devices, including AI-based software algorithms for image-based object detection, lesion detection, and classification. The firm offers image-based situational judgment algorithms for automatic air injection and cleaning, as well as 3D reconstruction of the human body through 6D pose and depth inference. Additionally, the company also provides services such as motorized endoscope systems with built-in motor control devices, light sources, and image processing.
Who invested in MedInTech
11 investors across 4 rounds
See all investors in MedInTech
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about MedInTech
Who invested in MedInTech?
MedInTech has 11 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MedInTech raised?
MedInTech has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did MedInTech last raise money?
MedInTech's most recent round on record is a Series B, in May 2024.
What does MedInTech do?
MedInTech is a medical devices & equipment company.
Where is MedInTech headquartered?
MedInTech is headquartered in Seoul, South Korea.
Which VCs invest in companies like MedInTech?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at MedInTech's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like MedInTech? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.